- Home
- LEGN vs XENE Comparison
LEGN vs XENE Comparison
Compare LEGN & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LEGN | XENE |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 3.7B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LEGN | XENE |
|---|---|---|
| Price | $17.42 | $40.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 18 |
| Target Price | $42.46 | ★ $71.69 |
| AVG Volume (30 Days) | ★ 2.3M | 1.2M |
| Earning Date | 11-10-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $311,000.00 |
| Revenue This Year | $38.71 | N/A |
| Revenue Next Year | $18.83 | $1,367.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.24 | $33.38 |
| 52 Week High | $37.50 | $72.66 |
Technical Indicators
Market Signals| Indicator | LEGN | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 37.79 | 56.24 |
| Support Level | $17.43 | $33.38 |
| Resistance Level | $19.92 | $43.67 |
| Average True Range (ATR) | 1.50 | 1.40 |
| MACD | -0.47 | 0.87 |
| Stochastic Oscillator | 1.15 | 79.38 |
Price Performance
Historical ComparisonAbout LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.